Targeted Therapy Against All Three VEGF Receptors by Cediranib Enhances the Antitumor and Anti-metastatic Effects of Paclitaxel and Radiation in an Orthotopic Human Lung Cancer Model

Targeted Therapy Against All Three VEGF Receptors by Cediranib Enhances the Antitumor and Anti-metastatic Effects of Paclitaxel and Radiation in an Orthotopic Human Lung Cancer Model

Bibliographic Details
Main Authors:	Takahashi, O, Komaki, R, Tailor, R, Juergensmeier, J, Ryan, A, Smith, P, Jacoby, J, Korshunova, M, Herbst, R, O'Reilly, MS
Format:	Journal article
Published:	2010

Similar Items

MEK1/2 blockade by AZD6244 (ARRY-142886) inhibits tumor growth and progression in an orthotopic human lung adenocarcinoma model with enhanced efficacy when combined with cediranib
by: Takahashi, O, et al.
Published: (2009)

Combined MEK and VEGFR inhibition in orthotopic human lung cancer models results in enhanced inhibition of tumor angiogenesis, growth, and metastasis
by: Takahashi, O, et al.
Published: (2012)

Combined MEK and VEGFR inhibition in orthotopic human lung cancer models results in enhanced inhibition of tumor angiogenesis, growth, and metastasis.
by: Takahashi, O, et al.
Published: (2012)

Antitumor and antiangiogenic activity of cediranib in a preclinical model of renal cell carcinoma.
by: Medinger, M, et al.
Published: (2009)

The effect of food on the single dose pharmacokinetics of cediranib
by: Jayson, G, et al.
Published: (2008)

Multi-center randomized phase II study comparing cediranib plus gefitinib with cediranib plus placebo in subjects with recurrent/progressive glioblastoma
by: Brown, N, et al.
Published: (2016)

Local Magnetic Hyperthermia and Systemic Gemcitabine/Paclitaxel Chemotherapy Triggers Neo-Angiogenesis in Orthotopic Pancreatic Tumors without Involvement of Auto/Paracrine Tumor Cell VEGF Signaling and Hypoxia
by: Wisdom O. Maduabuchi, et al.
Published: (2023-12-01)

Data of programmed death-ligand 1 expression and VEGF: Nivolumab, bevacizumab and paclitaxel For HER2-negative metastatic breast cancer
by: Yukinori Ozaki, et al.
Published: (2022-12-01)

SFRP2 is associated with increased adiposity and VEGF expression.
by: Crowley, R, et al.
Published: (2016)

VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors.
by: Mattila, M, et al.
Published: (2002)

Functional paclitaxel-manganese-doped mesoporous silica nanoparticles for orthotopic brain glioma targeted therapy
by: Ying Liu, et al.
Published: (2024-02-01)

Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation
by: Batchelor, Tracy T., et al.
Published: (2014)

Advantages of Tyrosine Kinase Anti-Angiogenic Cediranib over Bevacizumab: Cell Cycle Abrogation and Synergy with Chemotherapy
by: Jianling Bi, et al.
Published: (2021-07-01)

Randomised phase II trial of olaparib, chemotherapy, or olaparib and cediranib in patients with platinum-resistant ovarian cancer (OCTOVA): a study protocol
by: Mansouri, A, et al.
Published: (2021)

Effects of paclitaxel combined with carboplatin on expression of VEGF and tumor markers in ovarian cancer
by: TAN Shufen, YANG Xielan, YANG Linlin, LI Shuqing
Published: (2023-12-01)

Isobavachalcone Activates Antitumor Immunity on Orthotopic Pancreatic Cancer Model: A Screening and Validation
by: Xuanming Liu, et al.
Published: (2022-08-01)

Protocol to assess the antitumor efficacy of an immunotherapeutic peptide in syngeneic orthotopic glioma mouse models
by: Apeng Chen, et al.
Published: (2023-03-01)

Early changes in glioblastoma metabolism measured by MR spectroscopic imaging during combination of anti-angiogenic cediranib and chemoradiation therapy are associated with survival
by: Ovidiu C. Andronesi, et al.
Published: (2017-06-01)

Tetramethylpyrazine Enhances the Antitumor Effect of Paclitaxel by Inhibiting Angiogenesis and Inducing Apoptosis
by: Liang Zou, et al.
Published: (2019-06-01)

OCTOVA: A randomised phase II trial of olaparib, chemotherapy, or olaparib and cediranib in patients with BRCA-mutated platinumresistant ovarian cancer
by: Nicum, S, et al.
Published: (2017)

VEGF-D promotes the metastatic spread of tumor cells via the lymphatics.
by: Stacker, SA, et al.
Published: (2001)

Albumin-bound paclitaxel in the treatment of metastatic breast cancer
by: E V Artamonova
Published: (2017-01-01)

The effects of vandetanib on paclitaxel tumor distribution and antitumor activity in a xenograft model of human ovarian carcinoma.
by: Cesca, M, et al.
Published: (2009)

Hyaluronan Oligosaccharides-Coated Paclitaxel-Casein Nanoparticles with Enhanced Stability and Antitumor Activity
by: Man Wang, et al.
Published: (2022-09-01)

Comparative colloidal stability, antitumor efficacy, and immunosuppressive effect of commercial paclitaxel nanoformulations
by: Jun Ye, et al.
Published: (2021-07-01)

Organoids and metastatic orthotopic mouse model for mismatch repair-deficient colorectal cancer
by: Yurong Song, et al.
Published: (2023-09-01)

Evaluation of novel combined carbogen USPIO (CUSPIO) imaging biomarkers in assessing the antiangiogenic effects of cediranib (AZD2171) in rat C6 gliomas.
by: Burrell, J, et al.
Published: (2012)

Evaluation of novel combined carbogen USPIO (CUSPIO) imaging biomarkers in assessing the antiangiogenic effects of cediranib (AZD2171) in rat C6 gliomas
by: Burrell, J, et al.
Published: (2012)

The Vascular-Targeting Fusion Toxin VEGF121/rGel Inhibits the Growth of Orthotopic Human Bladder Carcinoma Tumors
by: Khalid Mohamedali, et al.
Published: (2005-10-01)

Targeted chemotherapy with nanoparticle albumin-bound paclitaxel (-paclitaxel) in metastatic breast cancer: which benefit for which patients?
by: Raffaella Palumbo, et al.
Published: (2016-05-01)

Targeting vascular endothelial growth factor receptor-1 and -3 with cediranib (AZD2171): effects on migration and invasion of gastrointestinal cancer cell lines.
by: Morelli, M, et al.
Published: (2009)

239 CSPG4-targeted CAR T cells demonstrate potent antitumor activity in an orthotopic murine model of anaplastic thyroid cancer
by: Cristina R Ferrone, et al.
Published: (2023-11-01)

Overexpression of Krüppel-Like Factor 9 Enhances the Antitumor Properties of Paclitaxel in Malignant Melanoma-Derived Cell Lines
by: Mohammed O. Altonsy, et al.
Published: (2023-04-01)

A two-part phase II study of cediranib in patients with advanced solid tumours: the effect of food on single-dose pharmacokinetics and an evaluation of safety, efficacy and imaging pharmacodynamics.
by: Mitchell, C, et al.
Published: (2011)

In Vivo Selection and Characterization of Metastatic Variants from Human Pancreatic Adenocarcinoma by Using Orthotopic Implantation in Nude Mice
by: Christiane J. Bruns, et al.
Published: (1999-04-01)

The results of orthotopic heart transplantation using the bicaval technique
by: B. M. Todurov, et al.
Published: (2023-06-01)

Population pharmacokinetics for oral paclitaxel in patients with advanced/metastatic solid tumors
by: Jimmy He, et al.
Published: (2022-07-01)

Erratum on: Chemotherapy in metastatic NSCLC – new regimens (pemetrexed, nab-paclitaxel)
by: Frontiers in Oncology Editorial Office
Published: (2014-10-01)

A case of metastatic basal cell carcinoma treated with carboplatin and paclitaxel
by: Chryssoula Papageorgiou, et al.
Published: (2023-01-01)

Structuration, practice theory, ethnography and migration: bringing it all together
by: O’Reilly, K
Published: (2012)